A one-sided but engrossing insider’s view of corporate scheming behind the vaccine triumphs.
Tumultuous battles among shareholders and management have roiled the Chinese company that makes a leading Covid-19 vaccine, according to this business book.
Halesworth recaps the history and fortunes of Sinovac, a Beijing biopharmaceutical firm and maker of the CoronaVac vaccine, from a deeply informed but materially interested perspective. He’s the founder and portfolio manager of Heng Ren Partners, a Boston hedge fund that owns Sinovac stock. He starts with an upbeat but sketchy rundown of CoronaVac’s success as an easy-to-store vaccine, with hundreds of millions of doses sold to developing countries despite its mediocre performance. (Studies put its efficacy in preventing mild and severe infections at 50.4% in Brazil.) The author soon turns from science to the book’s focus: disputes between Sinovac’s management and some of its investors over company governance and stock buyouts. The main issue was a 2016 Sinovac buyout proposal that offered investors $6.18 per share, a figure that Halesworth argues was far too low for the company’s true valuation. He further claims that Sinovac persistently played down the company’s prospects in order to keep the share price and the buyout cost low. The thorny situation became a rivalry between chairman and CEO Weidong Yin and his former partner Aihua Pan, leader of a dissident investors’ group that presented a competing buyout bid of $7 (later $8) per share. In Halesworth’s telling, the Pan Group won majority support in a shareholders’ vote, but when the Yin Group clung to power and issued new shares to friendly investors, things turned nasty. According to Sinovac, Pan Group minions tried to occupy the firm’s Beijing facilities and the police got involved. The struggle then proceeded down a labyrinth of lawsuits.
Halesworth gives an absorbing account of this contentious episode, complete with intriguing characters and a classic shareholder-meeting showdown where wily lawyer James Chang turned the tables on the Yin Group’s complacent board. The author sets it against a cogent analysis of the difficulties of the vaccine business—Sinovac’s SARS vaccine suddenly lost its potential market when that pandemic fizzled in 2005—and of the traps awaiting Americans who invest in China. He contends that opaque Chinese companies are listed on American stock exchanges but are beyond the reach of United States regulators. Halesworth elaborates this critique in prose that’s lucid and lively. (“After going private, they would often do a new stock offering in China for a new stock listing to trade at three to five times the price paid to buy out shareholders in the United States. These were not your father’s Chinese Communists.”) But he does have a stake in the proceedings, and it shows. He did not favor the Yin Group’s “lowball squeeze out,” and he reprints part of an open letter questioning the accounting and ethics of Sinovac’s buyout proposal. The book contains much scolding and lobbying of company management, including suggestions for reconfiguring the board and hiring a PR firm, along with calls for both sides to withdraw the lawsuits so that Sinovac investors can better profit from the bull market in biotech and vaccines. Readers and investors will find rich food for thought from Halesworth’s take on the Sinovac wrangles, but they should keep in mind that he’s not a neutral observer.
A one-sided but engrossing insider’s view of corporate scheming behind the vaccine triumphs.Pub Date: Feb. 1, 2021
ISBN: 979-8-70-609378-5
Page Count: 117
Publisher: Self
Review Posted Online: April 8, 2021
Kirkus Reviews Issue: May 15, 2021
Review Program: Kirkus Indie
A philosophically rich critique of state violence and mass apathy.
An Egyptian Canadian journalist writes searchingly of this time of war.
“Rules, conventions, morals, reality itself: all exist so long as their existence is convenient to the preservation of power.” So writes El Akkad, who goes on to state that one of the demands of modern power is that those subject to it must imagine that some group of people somewhere are not fully human. El Akkad’s pointed example is Gaza, the current destruction of which, he writes, is causing millions of people around the world to examine the supposedly rules-governed, democratic West and declare, “I want nothing to do with this.” El Akkad, author of the novel American War (2017), discerns hypocrisy and racism in the West’s defense of Ukraine and what he views as indifference toward the Palestinian people. No stranger to war zones himself—El Akkad was a correspondent in Afghanistan and Iraq—he writes with grim matter-of-factness about murdered children, famine, and the deliberate targeting of civilians. With no love for Zionism lost, he offers an equally harsh critique of Hamas, yet another one of the “entities obsessed with violence as an ethos, brutal in their treatment of minority groups who in their view should not exist, and self-decreed to be the true protectors of an entire religion.” Taking a global view, El Akkad, who lives in the U.S., finds almost every government and society wanting, and not least those, he says, that turn away and pretend not to know, behavior that we’ve seen before and that, in the spirit of his title, will one day be explained away until, in the end, it comes down to “a quiet unheard reckoning in the winter of life between the one who said nothing, did nothing, and their own soul.”
A philosophically rich critique of state violence and mass apathy.Pub Date: Feb. 25, 2025
ISBN: 9780593804148
Page Count: 224
Publisher: Knopf
Review Posted Online: Dec. 14, 2024
Kirkus Reviews Issue: Jan. 15, 2025
BOOK REVIEW
BOOK REVIEW
A passionate and accessible guide to humanizing the workplace.
Helbig and Norman present a game plan for making leadership more responsively human.
In this expanded update to The Psychological Safety Playbook: Lead More Powerfully by Being More Human (2023), the authors provide “practical strategies for responding to resistance, sparking change, embodying the change we want to see, and moving forward deliberately,” specifically in a business setting. They suggest ways to encourage what they call “changemakers” through the use of five key “plays” from their playbook: Communicate Courageously, Master the Art of Listening, Manage Your Reactions (“shift from automatic reaction to conscious response to stay better connected to yourself and others”), Embrace Risk and Failure, and Design Inclusive Rituals. The goal is to ensure that organizational cultures promote psychological safety, guided by leaders who “walk the talk” by emphasizing their own humanity at every turn. (“We must be the first to share our own failures with our teams, which will start to make it possible for others to do the same.”) This call for example-setting is sounded throughout the book as Helbig and Norman urge their target audience (leaders and would-be leaders) to go beyond mere instruction and instead embody the qualities they want to see in their subordinates, such as continuous learning, active curiosity, and self-reflection. Each chapter includes a detailed “Recommended Reading” section and text with extensive numbered and bulleted points formatted to make the core concepts more immediately digestible. The authors effectively employ clear and empathetic prose to assure readers that psychological safety is slow to build and quick to break, observing that such safety requires steady attention and delivers outsize payoffs as a result. They refreshingly ground a great deal of the material in psychology and neuroscience, pointing out, for instance, that research has demonstrated that the parasympathetic nervous system responds to honest appreciation, which improves creative thinking. Some wistful readers might consider some of the authors’ suggestions beyond the reach of their own organizations, as when group facilitators are advised to “gently intervene when someone dominates the conversation,” but hope springs eternal.
A passionate and accessible guide to humanizing the workplace.Pub Date: May 19, 2026
ISBN: 9798993550503
Page Count: 170
Publisher: Crazy Idea Press
Review Posted Online: April 23, 2026
Review Program: Kirkus Indie
BOOK REVIEW
© Copyright 2026 Kirkus Media LLC. All Rights Reserved.
Follow
Popular in this Genre
We can’t wait for you to join Kirkus!
It’s free and takes less than 10 seconds!
Already have an account? Log in.
OR
Sign in with GoogleTrouble signing in? Retrieve credentials.
Welcome Back!
OR
Sign in with GoogleTrouble signing in? Retrieve credentials.
